GILEAD SCIENCES, INC. reported revenue of $7.80B for the period ended 2026-06-30, +10.2% year on year. Net income was $-10.50B, a -134.5% net margin on a 79.8% gross margin. The largest revenue line is US at 72% of the total. Free cash flow for the period was $3.43B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $7.80B | +10.2% |
| Gross profit | $6.22B | — |
| Operating income | $-10.39B | — |
| Net income | $-10.50B | -635.5% |
| Gross margin | 79.8% | Net margin -134.5% |
| Revenue Q/Q | +12.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| US | $5.60B | 71.8% |
| Europe | $1.32B | 17.0% |
| Rest Of World | $0.88B | 11.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $1.58B | 20.2% |
| SG&A | $1.92B | 24.6% |
| Tax & other | $0.10B | 1.3% |
| Item | Amount |
|---|---|
| Total assets | $49.36B |
| Total liabilities | $37.62B |
| Shareholders' equity | $11.74B |
| Equity / assets | 23.8% |
| Operating cash flow | $3.57B |
| Capital expenditure | $0.14B |
| Free cash flow | $3.43B |
| Cash conversion (OCF / net income) | -34% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
GPN ・ GL ・ GDDY ・ GS ・ HAL ・ HIG ・ HAS ・ HCA ・ DOC ・ HSIC ・ HSY ・ HPE
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies